NICE INSIGHT REPORT

Mammalian Cell Culture, Biologics: Market Insight, CDMO Pricing and Competitor Benchmarking

Updated Monthly
  • 2025 CDMO pricing data for 105 clinical and commercial mammalian biologics development and manufacturing RFP service line items
  • Exhaustive directory of capabilities profiles for the top 77 biologics CDMOs specializing in mammalian cell culture
  • Technical focus on emerging antibody formats, with an in-depth look at the growing pace of bispecific antibody clinical trials
  • Includes Nice Insight’s Clinical Trials Landscape tool — an in-depth custom research platform for current and upcoming mammalian biologics trials, sourced from the FDA Clinical Trials Database
Learn More
Mammalian Cell Culture, Biologics

Key market insights for innovators, CDMOs and investors in the biologics industry.

Make better decisions with our pricing report

Discover the mammalian cell culture contract development and manufacturing market with our comprehensive study on top CDMOs and insights into manufacturing trends. Benchmark your business with our in-depth pricing studies, which use years of primary data, to see how to best position your business. Dive into the focus on production of antibodies and antibody-based therapeutics.

 

Essential mammalian cell culture analysis

Understand the unique complexities of developing mammalian-based biologics and the trends and technologies shaping the market from exclusive insights from PhD scientists, NMEs and respected voices in the biopharma industry.

Update cookies preferences